Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:893-901
Published online before print February 19, 2007, doi: 10.1161/01.HYP.0000259669.40991.1e
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
49/4/893    most recent
01.HYP.0000259669.40991.1ev1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kang, K.-T.
Right arrow Articles by Pollock, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kang, K.-T.
Right arrow Articles by Pollock, J. S.
Related Collections
Right arrow Other hypertension
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Hypertension. 2007;49:893.)
© 2007 American Heart Association, Inc.


Original Articles

Novel Nitric Oxide Synthase–Dependent Mechanism of Vasorelaxation in Small Arteries From Hypertensive Rats

Kyu-Tae Kang; Jennifer C. Sullivan; Jennifer M. Sasser; John D. Imig; Jennifer S. Pollock

From the Vascular Biology Center, Medical College of Georgia, Augusta.

Correspondence to Jennifer S. Pollock, Vascular Biology Center, CB 3213, Medical College of Georgia, Augusta, GA 30912. E-mail jpollock{at}mcg.edu

To determine the mechanism(s) involved in vasorelaxation of small arteries from hypertensive rats, normotensive (NORM), angiotensin II-infused (ANG), high-salt (HS), ANG high-salt (ANG/HS), placebo, and deoxycorticosterone acetate-salt rats were studied. Third-order mesenteric arteries from ANG or ANG/HS displayed decreased sensitivity to acetylcholine (ACh)-induced vasorelaxation compared with NORM or HS, respectively. Maximal relaxations were comparable between groups. Blockade of Ca2+-activated K+ channels had no effect on ANG versus blunting relaxation in NORM (log EC50: –6.8±0.1 versus –7.2±0.1 mol/L). NO synthase (NOS) inhibition abolished ACh-mediated relaxation in small arteries from ANG, ANG/HS, and deoxycorticosterone acetate-salt versus blunting relaxation in NORM, HS, and placebo (% maximal relaxation: ANG: 2.7±1.8; ANG/HS: 7.2±3.2; NORM: 91±3.1; HS: 82.1±13.3; deoxycorticosterone acetate-salt: 35.2±17.7; placebo: 79.3±10.3), indicating that NOS is the primary vasorelaxation pathway in these arteries from hypertensive rats. We hypothesized that NO/cGMP signaling and NOS-dependent H2O2 maintains vasorelaxation in small arteries from ANG. ACh increased NOS-dependent cGMP production, indicating that NO/cGMP signaling is present in small arteries from ANG (55.7±6.9 versus 30.5±5.1 pmol/mg), and ACh stimulated NOS-dependent H2O2 production (ACh: 2.8±0.2 µmol/mg; N{omega}-nitro-L-arginine methyl ester hydrochloride+ACh: 1.8±0.1 µmol/mg) in small arteries from ANG. H2O2 induced vasorelaxation and catalase blunted ACh-mediated vasorelaxation. In conclusion, Ca2+-activated K+ channel–mediated relaxation is dysfunctional in small mesenteric arteries from hypertensive rats, and the NOS pathway compensates to maintain vasorelaxation in these arteries through NOS-mediated cGMP and H2O2 production.


Key Words: NO • hydrogen peroxide • hypertension • endothelium-dependent vasorelaxation • mesenteric arteries • aorta




This article has been cited by other articles:


Home page
HypertensionHome page
S. Chrissobolis, S. P. Didion, D. A. Kinzenbaw, L. I. Schrader, S. Dayal, S. R. Lentz, and F. M. Faraci
Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II-Induced Vascular Dysfunction
Hypertension, April 1, 2008; 51(4): 872 - 877.
[Abstract] [Full Text] [PDF]